skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Gentlemen:
I owned shares of of ret and did some tax loss selling. I can now buy back, however, I am not sure if I should bother to buy back this company. Donville, Kent, who Peter had made mention of their small cap report, and remarked that it was interesting believes that it is an iconic Canadian Brand, and with some changes believes it could be a five bagger. Please give a detailed report with reasons.
Thanks,
BEN.
Read Answer Asked by BEN on December 14, 2023
Q: This was on my radar a few years ago and just returned to look at it. What happened? Pretty fantastic revenue growth (especially this year) but EPS and free cash flow plummeted in to negative territory. Is this just bad management of personnel or inventory, or?

I see this could be a great opportunity, but the recent bumps concern me.

C.
Read Answer Asked by Cameron on December 13, 2023
Q: Looking at todays earnings report all seems to be going good here, I've held a small position for a while and have done nicely, loving the momentum and would like to add more, the liquidity is a bit of a concern. In your experience what typically helps improve liquidity and would you expect a slow and steady rise here in that regard and share price?
Read Answer Asked by Charles on December 13, 2023
Q: TMDX is in the business of delivering viable human organs for transplant operations. Their technology markedly improves organ viability compared to the previous methodology of placing organs on ice. Future competitors must demonstrate via clinical trials that their technology is significantly better than that of TMDX. Seems like a decent moat. TMDX took on further debt to by a small airline to facilitate organ delivery which was being hampered by lack of reliable air transport. I would appreciate your expertise in determining if TMDX has a valid business model that warrants investment in their stock at its current price.
Read Answer Asked by John on December 13, 2023
Q: Hi Team,
What’s driving the relentless selling of Well lately? I don’t see why investors are taking a negative view on the name recently. Is this giving us a chance to buy more at basement bottom prices here ? Price targets average over $8 today and the stocks trading down towards the $3 range. Your take on the name is appreciated. Thanks

Shane
Read Answer Asked by Shane on December 13, 2023
Q: I’m selling Appian (APPN) and Fulgent Genetics (FLGT) for a tax loss and am wondering what suitable proxies would be. Or would you recommend just selling, and buying something more promising? (I’m not limited by sector here.) I have more confidence in Appian than in Fulgent. Is that appropriate in your opinion?
Read Answer Asked by Camille on December 12, 2023
Q: I was just about to give up on Sylogist because of its downward trend over the past 5 weeks in a strong market. Then I discovered that CFRA rates it a Strong Buy!! I know that their report is algorithm-generated, but still! I checked out other CFRA algorithm-generated reports for other small-cap Canadian tech stocks and couldn’t find another Strong Buy (lots of sells). I originally signed up for 5i Research because you cover small Canadian companies. SYZ never issues stock, so there's no analyst coverage. Only algorithms. So how much credence would you put on CFRA's algorithm? What is causing it to generate a Strong Buy for SYZ?
Read Answer Asked by David on December 11, 2023
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!